Medical Device Network on MSN
Roche builds MRD testing arsenal in $595M Saga Diagnostics buyout
Roche subsidiary, Foundation Medicine, is boosting its presence in the MRD testing space, which it touts as “one of the ...
Roche's Foundation Medicine will strengthen its testing portfolio by adding Saga's Pathlight tumor-informed molecular residual disease platform.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results